HopeStage
Back to all studies
Recruitment unclearEUCTR 2007-000479-40

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with Bipolarity: searching for the antidepressant and mood stabilising neurophysiology

This historical record does not confirm current site availability.

Historical research recordGermany
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with bipolarity. Other eligibility criteria apply.

Listed locations
Germany
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruitment unclear
Enrollment listed in the registry
Not clearly listed
Sponsor
Department of Psychiatry, RWTH Aachen
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Germany
Age range
Not clearly listed
Official registry ID
EUCTR 2007-000479-40
Official title
Show the full official title

Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology

Recruitment & locations

Status unknown

Germany

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Department of Psychiatry, RWTH Aachen.

Who can participate?

This study is for people with bipolarity. Other eligibility criteria apply.

Want to explore more studies?

Explore studies